A cheap and widely available antidepressant drug called fluvoxamine may reduce COVID-19 patients’ risk of serious illness requiring hospitalization, according to a new study. The trial included almost 1,500 unvaccinated outpatients in Brazil. All of the patients tested positive for infection with SARS-CoV-2 and were deemed to be at high risk for a severe case…  read on >  read on >

Women’s symptoms of post-traumatic stress disorder (PTSD) may vary with their menstrual cycle, which could have implications for diagnosis and treatment, researchers say. Their study included 40 women between 18 and 33 years of age who had PTSD after experiencing or witnessing a traumatic event, such as sexual violence or a serious injury. “For women…  read on >  read on >

Routine face mask ventilation during an operation doesn’t increase the surgical team’s risk of coronavirus infection, according to a new study. Face mask ventilation is typically used for surgical patients under general anesthesia. However, its designation as an “aerosol-generating procedure” by the World Health Organization has altered operating room procedures and efficiency during the COVID-19…  read on >  read on >

WEDNESDAY, Oct. 27 2021Midlife vision problems could increase women’s risk of depression, new research suggests. Rates of eye problems and depression rise during midlife, but knowledge about how vision affects depression at that time has been limited. The new study identified a significant link between impaired vision and development of depression. “Given that the combination…  read on >  read on >

Teenagers have followed the vaping trend into marijuana use, with recent studies chronicling a boom in pot vaping among adolescents in the United States and Canada, researchers report. The percentage of teens who’ve experimented with vaped pot has more than doubled in recent years, and vaping among frequent marijuana users has quadrupled, according to the…  read on >  read on >